DiviDrip · TRDA

TRDA — Entrada Therapeutics, Inc.

TRDA is Entrada Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $7.17. Market cap: $284M. Capital Quality Rank: 11/100 — Systemic risk.

Stock snapshot

Price$7.17
Market cap$284M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)11 / 100 · Systemic risk
ROIC (TTM)-57.8%
Shareholder buyback yield-5.72%
Altman Z-score zoneDistress

About TRDA

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Listed2021Employees152HQBoston, MASectorHealthcareWebsiteentradatx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TRDA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TRDA's current stock price?

TRDA (Entrada Therapeutics, Inc.) is currently trading at $7.17.

Does TRDA pay a dividend?

TRDA (Entrada Therapeutics, Inc.) does not currently pay a regular dividend.

What is TRDA's Capital Quality Rank?

TRDA has a Capital Quality Rank of 11/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TRDA in DiviDrip

Add TRDA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow